ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Aug 23, 2016
What’s Going on With Corrections Corp?
Image Source: Dave Nakayama.  Let’s take a look at what happened in the past few days regarding Corrections Corp, a Department of Justice decision, and our fair value estimate of the firm’s shares.
Aug 22, 2016
Cisco’s Awesome Dividend Growth Potential
Image Source: BY-YOUR-⌘. A holding in both newsletter portfolios, Cisco announced a restructuring initiative along with its fiscal fourth quarter results August 17. We’re huge fans of its dividend growth potential.
Aug 18, 2016
Videos: Valuentum's Four-Part Education Workshop
Purchase the videos of Valuentum's four-part education workshop.
Aug 18, 2016
Little Progress Seen in Iron Ore Market Balancing
Image Source: Peter Craven. Not much has changed in our view of the iron ore market and the players within. We continue to believe the rally in prices in early 2016 does not represent a sustainable outlook for the metal.
Aug 15, 2016
Priceline Higher After Outperforming Conservative Guidance
Best Ideas Newsletter portfolio holding Priceline reported a solid second quarter of 2016 as the summer travel season began.
Aug 15, 2016
Brand Image Taking Center Stage in Aspirational Goods
Coach, Michael Kors, and other "aspirational" goods sellers have been forced to adjust their strategies in an increasingly difficult operating environment.
Aug 14, 2016
Dividend Increases/Decreases for the Week Ending August 12
Let's take a look at companies raising/lowering their dividends this week.
Aug 12, 2016
Industrials Empty Tool Box Amid Tough Operating Environment
Let’s take a look at calendar second-quarter reports for a variety of industrial entities.
Aug 10, 2016
Oncology News a Key Driver of Big Pharma
Image Source: Images Money. Oncology product portfolios and pipelines have been key factors in the big pharma industry as of late.
Aug 9, 2016
Lockheed Martin Overpriced, Leidos “Dead” Money…Maybe
Image Source: Maryland GovPics. Lockheed Martin shareholders have a choice to make, but it may not be the one they are thinking about. We think the Leidos deal is largely a wash, and while we don’t dislike the company, we don’t think Leidos is a no-brainer particularly in light of its net debt load. The real question, in our opinion, is whether either of the two, Lockheed Martin or Leidos, are worthy of your investment dollars at present levels. One is overpriced, while the other looks like dead money.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.